Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 2/2: (HNSN) (AVXL) (KORS) Higher; (CBYL) (PXLW) (IDTI) Low

February 2, 2016 12:55 PM
Carbylan Therapeutics (Nasdaq: CBYL) 69.0% LOWER; announced top-line results from COR1.1, its first Phase III trial of Hydros-TA for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles